{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T22:28:22Z","timestamp":1771626502627,"version":"3.50.1"},"reference-count":97,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.pupt.2010.05.001","type":"journal-article","created":{"date-parts":[[2010,5,17]],"date-time":"2010-05-17T06:22:33Z","timestamp":1274077353000},"page":"493-500","source":"Crossref","is-referenced-by-count":55,"title":["Biomarkers in COPD"],"prefix":"10.1016","volume":"23","author":[{"given":"Mario","family":"Cazzola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Novelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2010.05.001_bib1","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.coph.2008.04.001","article-title":"The clinical utility of biomarkers in asthma and COPD","volume":"8","author":"Snell","year":"2008","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.pupt.2010.05.001_bib2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.tibtech.2004.06.005","article-title":"Biomarker discovery and validation: technologies and integrative approaches","volume":"22","author":"Ilyin","year":"2004","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.pupt.2010.05.001_bib3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1164\/rccm.200510-1659PP","article-title":"Pulmonary biomarkers in chronic obstructive pulmonary disease","volume":"174","author":"Barnes","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2010.05.001_bib4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.pupt.2005.05.001","article-title":"Markers of disease severity in chronic obstructive pulmonary disease","volume":"19","author":"Franciosi","year":"2006","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.pupt.2010.05.001_bib5","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1183\/09031936.00099306","article-title":"Outcomes for COPD pharmacological trials: from lung function to biomarkers","volume":"31","author":"Cazzola","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2010.05.001_bib6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1513\/pats.200904-019DS","article-title":"Biomarkers in chronic obstructive pulmonary disease","volume":"6","author":"Sin","year":"2009","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.pupt.2010.05.001_bib7","first-page":"403","article-title":"Clinical use of exhaled biomarkers in COPD","volume":"2","author":"O\u2019Reilly","year":"2007","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.pupt.2010.05.001_bib8","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1164\/ajrccm.152.2.7543345","article-title":"Acute and chronic effects of cigarette smoking on exhaled nitric oxide","volume":"152","author":"Kharitonov","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2010.05.001_bib9","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1164\/ajrccm.162.5.9910112","article-title":"Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease","volume":"162","author":"Papi","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2010.05.001_bib10","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1164\/ajrccm.162.2.9909105","article-title":"Production of endogenous nitric oxide in chronic obstructive pulmonary disease and patients with cor pulmonale. Correlates with echo-Doppler assessment","volume":"162","author":"Clini","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2010.05.001_bib11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1164\/rccm.200507-1161WS","article-title":"Long-term oxygen treatment in chronic obstructive pulmonary disease: recommendations for future research: an NHLBI workshop report","volume":"174","author":"Croxton","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2010.05.001_bib12","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1152\/japplphysiol.00950.2003","article-title":"Modeling pulmonary nitric oxide exchange","volume":"96","author":"George","year":"2004","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.pupt.2010.05.001_bib13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1183\/09031936.04.00125304","article-title":"Exhaled nitric oxide from lung periphery is increased in COPD","volume":"26","author":"Brindicci","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2010.05.001_bib14","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1183\/09031936.03.00098203","article-title":"Decreased haem oxygenase-1 and increased inducible nitric oxide synthase in the lung of severe COPD patients","volume":"21","author":"Maestrelli","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2010.05.001_bib15","first-page":"1051","article-title":"Reproducibility of exhaled carbon monoxide measurements and its circadian variation in normal subjects","volume":"157","author":"Kharitonov","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2010.05.001_bib16","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1378\/chest.117.3.758","article-title":"Breath carbon monoxide as an indication of smoking habit","volume":"117","author":"Middleton","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2010.05.001_bib17","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1378\/chest.120.2.496","article-title":"Exhaled carbon monoxide and nitric oxide in COPD","volume":"120","author":"Montuschi","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2010.05.001_bib18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1183\/09031936.05.00085804","article-title":"Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease","volume":"25","author":"Borrill","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2010.05.001_bib19","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1164\/rccm.200111-068OC","article-title":"pH in expired breath condensate of patients with inflammatory airway diseases","volume":"165","author":"Kostikas","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2010.05.001_bib20","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1378\/chest.08-1007","article-title":"Impact of age on pH, 8-isoprostane, and nitrogen oxides in exhaled breath condensate","volume":"135","author":"Cruz","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2010.05.001_bib21","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1164\/ajrccm.162.3.2001063","article-title":"Exhaled 8-isoprostane as an in vivo biomarker of oxidative stress in patients with COPD and healthy smokers","volume":"162","author":"Montuschi","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2010.05.001_bib22","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1378\/chest.124.4.1373","article-title":"Oxidative stress in expired breath condensate of patients with COPD","volume":"124","author":"Kostikas","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2010.05.001_bib23","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000106377","article-title":"Exhaled breath condensate 8-isoprostane, clinical parameters, radiological indices and airway inflammation in COPD","volume":"75","author":"Makris","year":"2008","journal-title":"Respiration"},{"key":"10.1016\/j.pupt.2010.05.001_bib24","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.rmed.2005.08.009","article-title":"Exhaled breath condensate levels of 8-isoprostane, growth related oncogene and monocyte chemoattractant protein-1 in patients with chronic obstructive pulmonary disease","volume":"100","author":"Ko","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.pupt.2010.05.001_bib25","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/thorax.58.4.294","article-title":"Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD","volume":"58","author":"Biernacki","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2010.05.001_bib26","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1378\/chest.127.5.1553","article-title":"Leukotriene B4 in exhaled breath condensate and sputum supernatant in patients with COPD and asthma","volume":"127","author":"Kostikas","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2010.05.001_bib27","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1183\/09031936.03.00022203","article-title":"Increased inflammatory markers in the exhaled breath condensate of cigarette smokers","volume":"21","author":"Carpagnano","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2010.05.001_bib28","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1164\/ajrccm.154.3.8810624","article-title":"Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease","volume":"154","author":"Dekhuijzen","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2010.05.001_bib29","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/rmed.1999.0574","article-title":"Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking","volume":"93","author":"Nowak","year":"1999","journal-title":"Respir Med"},{"key":"10.1016\/j.pupt.2010.05.001_bib30","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1378\/chest.130.4.1157","article-title":"Repeated sputum inductions induce a transient neutrophilic and eosinophilic response","volume":"130","author":"van der Vaart","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2010.05.001_bib31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/15412550600651339","article-title":"Safety of sputum induction in moderate-to-severe smoking-related chronic obstructive pulmonary disease","volume":"3","author":"Wilson","year":"2006","journal-title":"COPD"},{"key":"10.1016\/j.pupt.2010.05.001_bib32","first-page":"114","article-title":"Kronik obstruktif akciger hastalari ve astimlilarda indukte balgamda MMP-9 ve TIMP-1 duzeyleri","volume":"54","author":"Caliko\u011flu","year":"2006","journal-title":"Tuberk Toraks"},{"key":"10.1016\/j.pupt.2010.05.001_bib33","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5603\/ARM.28313","article-title":"Levels of CC-chemokine (MCP-1\u03b1, MIP-1\u03b2) in induced sputum of patients with chronic obstructive pulmonary disease and patients with chronic bronchitis","volume":"69","author":"Barczyk","year":"2001","journal-title":"Pneumonol Alergol Pol"},{"key":"10.1016\/j.pupt.2010.05.001_bib34","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/thorax.57.7.590","article-title":"Increased levels of the chemokines GRO\u03b1 and MCP-1 in sputum samples from patients with COPD","volume":"57","author":"Traves","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2010.05.001_bib35","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.rmed.2004.03.029","article-title":"Leptin as local inflammatory marker in COPD","volume":"99","author":"Broekhuizen","year":"2005","journal-title":"Respir Med"},{"key":"10.1016\/j.pupt.2010.05.001_bib36","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1042\/BST0370868","article-title":"Induced sputum: a window to lung pathology","volume":"37","author":"Nicholas","year":"2009","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.pupt.2010.05.001_bib37","first-page":"119","article-title":"Markers of airway inflammation in pulmonary diseases assessed by induced sputum","volume":"71","author":"Dragonieri","year":"2009","journal-title":"Monaldi Arch Chest Dis"},{"key":"10.1016\/j.pupt.2010.05.001_bib38","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/thx.51.3.267","article-title":"Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils","volume":"51","author":"St\u0103nescu","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2010.05.001_bib39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.rmed.2003.08.007","article-title":"Induced sputum CD8+ T-lymphocyte subpopulations in chronic obstructive pulmonary disease","volume":"98","author":"Tzanakis","year":"2004","journal-title":"Respir Med"},{"key":"10.1016\/j.pupt.2010.05.001_bib40","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1164\/rccm.2107139","article-title":"Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease","volume":"165","author":"Saetta","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2010.05.001_bib41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1183\/09031936.00023606","article-title":"8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD","volume":"29","author":"Kinnula","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2010.05.001_bib42","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/j.rmed.2009.05.023","article-title":"Interleukin-18 in induced sputum: association with lung function in chronic obstructive pulmonary disease","volume":"103","author":"Rovina","year":"2009","journal-title":"Respir Med"},{"key":"10.1016\/j.pupt.2010.05.001_bib43","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.200906-0857OC","article-title":"Identification of lipocalin and apolipoprotein A1 as biomarkers of chronic obstructive pulmonary disease","author":"Nicholas","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2010.05.001_bib44","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.rmed.2004.10.022","article-title":"Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma","volume":"99","author":"Culpitt","year":"2005","journal-title":"Respir Med"},{"key":"10.1016\/j.pupt.2010.05.001_bib45","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1465-9921-10-38","article-title":"N-\u03b1-PGP and PGP, potential biomarkers and therapeutic targets for COPD","volume":"10","author":"O\u2019Reilly","year":"2009","journal-title":"Respir Res"},{"key":"10.1016\/j.pupt.2010.05.001_bib46","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2249.2007.03451.x","article-title":"Increased intracellular T\u00a0helper 1 proinflammatory cytokine production in peripheral blood, bronchoalveolar lavage and intraepithelial T cells of COPD subjects","volume":"150","author":"Hodge","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.pupt.2010.05.001_bib47","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1183\/09031936.98.12020380","article-title":"Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease","volume":"12","author":"Pesci","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2010.05.001_bib48","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/thx.2004.024463","article-title":"Inflammatory cells in the airways in COPD","volume":"61","author":"O\u2019Donnell","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2010.05.001_bib49","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1183\/09031936.99.14510159","article-title":"Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease","volume":"14","author":"Soler","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2010.05.001_bib50","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jaci.2007.08.045","article-title":"Computed tomographic scan-diagnosed chronic obstructive pulmonary disease-emphysema: eotaxin-1 is associated with bronchodilator response and extent of emphysema","volume":"120","author":"Miller","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.pupt.2010.05.001_bib51","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/elps.200800722","article-title":"Lipid metabolite levels of prostaglandin D2 and eicosapentaenoic acid recovered from bronchoalveolar lavage fluid correlate with lung function of chronic obstructive pulmonary disease patients and controls","volume":"30","author":"Csanky","year":"2009","journal-title":"Electrophoresis"},{"key":"10.1016\/j.pupt.2010.05.001_bib52","first-page":"6S","article-title":"Assessment of airway inflammation: an overview","volume":"26","author":"Fabbri","year":"1998","journal-title":"Eur Respir J Suppl"},{"key":"10.1016\/j.pupt.2010.05.001_bib53","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1164\/rccm.200202-150WS","article-title":"Methods for the assessment of endobronchial biopsies in clinical research: application to studies of pathogenesis and the effects of treatment","volume":"168","author":"Jeffery","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2010.05.001_bib54","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cca.2005.06.008","article-title":"Laboratory markers for COPD in \u201csusceptible\u201d smokers","volume":"364","author":"Tzortzaki","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.pupt.2010.05.001_bib55","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1183\/09031936.06.00027705","article-title":"Variability of bronchial inflammation in chronic obstructive pulmonary disease: implications for study design","volume":"27","author":"Gamble","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2010.05.001_bib56","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1183\/09031936.00.15110900","article-title":"Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD","volume":"15","author":"Rutgers","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2010.05.001_bib57","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0954-6111(98)90389-4","article-title":"Neutrophils infiltrating bronchial epithelium in chronic obstructive pulmonary disease","volume":"92","author":"Pesci","year":"1998","journal-title":"Respir Med"},{"key":"10.1016\/j.pupt.2010.05.001_bib58","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1183\/09031936.00137006","article-title":"Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies","volume":"31","author":"Snoeck-Stroband","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2010.05.001_bib59","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1164\/ajrccm.158.4.9802078","article-title":"Severity of airflow limitation is associated with severity of airway inflammation in smokers","volume":"158","author":"Di Stefano","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2010.05.001_bib60","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1164\/rccm.200208-794OC","article-title":"Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease","volume":"168","author":"Qiu","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2010.05.001_bib61","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/thx.2009.113647","article-title":"Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD","volume":"64","author":"Di Stefano","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2010.05.001_bib62","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1365-2249.2009.03965.x","article-title":"T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients","volume":"157","author":"Di Stefano","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.pupt.2010.05.001_bib63","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.4049\/jimmunol.181.7.5167","article-title":"YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages","volume":"181","author":"L\u00e9tuv\u00e9","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.pupt.2010.05.001_bib64","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1378\/chest.09-1029","article-title":"Altered surfactant protein-A expression in type II pneumocytes in COPD","volume":"137","author":"Vlachaki","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2010.05.001_bib65","first-page":"157","article-title":"Markers of early disease and prognosis in COPD","volume":"4","author":"Dahl","year":"2009","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.pupt.2010.05.001_bib66","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/thx.2005.042200","article-title":"C-reactive protein in patients with COPD, control smokers and non-smokers","volume":"61","author":"Pinto-Plata","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2010.05.001_bib67","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1136\/thx.2006.059808","article-title":"C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease","volume":"61","author":"Man","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2010.05.001_bib68","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/thx.2006.066969","article-title":"Systemic inflammation and decline in lung function in a general population: a prospective study","volume":"62","author":"Fogarty","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2010.05.001_bib69","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/j.rmed.2006.03.027","article-title":"Change in C-reactive protein levels and FEV1 decline: a longitudinal population-based study","volume":"100","author":"Shaaban","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.pupt.2010.05.001_bib70","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1378\/chest.128.4.1995","article-title":"Airway and systemic inflammation and decline in lung function in patients with COPD","volume":"128","author":"Donaldson","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2010.05.001_bib71","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.rmed.2009.01.021","article-title":"Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease","volume":"103","author":"Higashimoto","year":"2009","journal-title":"Respir Med"},{"key":"10.1016\/j.pupt.2010.05.001_bib72","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1164\/rccm.200605-713OC","article-title":"C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease","volume":"175","author":"Dahl","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2010.05.001_bib73","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1378\/chest.07-2433","article-title":"C-reactive protein levels and survival in patients with moderate to very severe COPD","volume":"133","author":"de Torres","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2010.05.001_bib74","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1182\/blood.V56.2.145.145","article-title":"The structure and biologic activities of plasma fibronectin","volume":"56","author":"Mosesson","year":"1980","journal-title":"Blood"},{"key":"10.1016\/j.pupt.2010.05.001_bib75","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1183\/09031936.00153207","article-title":"Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD?","volume":"32","author":"Man","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2010.05.001_bib76","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/thx.2005.041996","article-title":"Raised CRP levels mark metabolic and functional impairment in advanced COPD","volume":"61","author":"Broekhuizen","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2010.05.001_bib77","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000207793","article-title":"Increased serum inflammatory markers in the absence of clinical and skeletal muscle inflammation in patients with chronic obstructive pulmonary disease","volume":"78","author":"Piehl-Aulin","year":"2009","journal-title":"Respiration"},{"key":"10.1016\/j.pupt.2010.05.001_bib78","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1164\/ajrccm.164.6.2010067","article-title":"Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease","volume":"164","author":"Dahl","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2010.05.001_bib79","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/thx.2003.019588","article-title":"Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis","volume":"59","author":"Gan","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2010.05.001_bib80","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/aje\/kwn174","article-title":"Inflammatory markers and longitudinal lung function decline in the elderly","volume":"168","author":"Jiang","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.pupt.2010.05.001_bib81","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/thx.2008.102079","article-title":"Plasma markers of inflammation and incidence of hospitalisations for COPD: results from a population-based cohort study","volume":"64","author":"Engstrom","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2010.05.001_bib82","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1165\/ajrcmb.23.2.3855","article-title":"Production of the acute-phase protein lipopolysaccharide-binding protein by respiratory type II epithelial cells: implications for local defense to bacterial endotoxins","volume":"23","author":"Dentener","year":"2000","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pupt.2010.05.001_bib83","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/1753465808088903","article-title":"Surfactant protein D: a lung specific biomarker in COPD?","volume":"2","author":"Sin","year":"2008","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.pupt.2010.05.001_bib84","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.molimm.2005.08.004","article-title":"Surfactant proteins SP-A and SP-D: structure, function and receptors","volume":"43","author":"Kishore","year":"2006","journal-title":"Mol Immunol"},{"key":"10.1016\/j.pupt.2010.05.001_bib85","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2466-7-13","article-title":"Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study","volume":"7","author":"Sin","year":"2007","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.pupt.2010.05.001_bib86","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1183\/09031936.00156508","article-title":"Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD","volume":"34","author":"Lomas","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2010.05.001_bib87","doi-asserted-by":"crossref","first-page":"e6865","DOI":"10.1371\/journal.pone.0006865","article-title":"The influence of radiographic phenotype and smoking status on peripheral blood biomarker patterns in chronic obstructive pulmonary disease","volume":"4","author":"Bon","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.pupt.2010.05.001_bib88","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1465-9921-10-113","article-title":"Eosinophil and T cell markers predict functional decline in COPD patients","volume":"10","author":"D\u2019Armiento","year":"2009","journal-title":"Respir Res"},{"key":"10.1016\/j.pupt.2010.05.001_bib89","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/thx.2008.098640","article-title":"Risk assessment in asthma and COPD: a potential role for biomarkers?","volume":"64","author":"Taylor","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2010.05.001_bib90","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1378\/chest.08-0455","article-title":"Biomarkers in COPD: are we there yet?","volume":"133","author":"Sin","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2010.05.001_bib91","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1165\/rcmb.2008-0114OC","article-title":"Molecular biomarkers for quantitative and discrete COPD phenotypes","volume":"40","author":"Bhattacharya","year":"2009","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pupt.2010.05.001_bib92","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1136\/thx.2008.105957","article-title":"COPD and biomarkers: the search goes on","volume":"63","author":"Turino","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2010.05.001_bib93","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.rmed.2009.06.002","article-title":"Biomarkers of lung damage associated with tobacco smoke in induced sputum","volume":"103","author":"Comandini","year":"2009","journal-title":"Respir Med"},{"key":"10.1016\/j.pupt.2010.05.001_bib94","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/thx.2006.064428","article-title":"Profiling serum biomarkers in patients with COPD: associations with clinical parameters","volume":"62","author":"Pinto-Plata","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2010.05.001_bib95","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1440-1843.2009.01608.x","article-title":"Correlation between serum biomarkers and\u00a0BODE index in patients with stable COPD","volume":"14","author":"Liu","year":"2009","journal-title":"Respirology"},{"key":"10.1016\/j.pupt.2010.05.001_bib96","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1513\/pats.200904-021DS","article-title":"Genetics and genomics of chronic obstructive pulmonary disease","volume":"6","author":"Silverman","year":"2009","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.pupt.2010.05.001_bib97","article-title":"Pharmacogenomics: role in medicines approval and clinical use","author":"Novelli","year":"2009","journal-title":"Public Health Genomics"}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553910000544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553910000544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T05:48:45Z","timestamp":1685598525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553910000544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":97,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S1094553910000544"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2010.05.001","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}